Rapid Response to Vedolizumab Therapy in Biologic-Naive Patients With Inflammatory Bowel Diseases-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Rapid Response to Vedolizumab Therapy in Biologic-Naive Patients With Inflammatory Bowel Diseases

Published:2019-01 Issue:1 Volume:17 Page:130-138.e7
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Feagan Brian G.,Lasch Karen,Lissoos Trevor,Cao Charlie,Wojtowicz Abigail M.,Khalid Javaria Mona,Colombel Jean-Frédéric

Funder

Takeda Pharmaceuticals U.S.A., Inc.

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference28 articles.

1. Ulcerative colitis;Ordas;Lancet,2012

2. Crohn's disease;Torres;Lancet,2017

3. Patient-reported outcome measures in inflammatory bowel disease;El-Matary;Can J Gastroenterol Hepatol,2014

4. Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): determining therapeutic goals for treat-to-target;Peyrin-Biroulet;Am J Gastroenterol,2015

5. Development of interim patient-reported outcome measures for the assessment of ulcerative colitis disease activity in clinical trials;Jairath;Aliment Pharmacol Ther,2015

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Short-term efficacy of vedolizumab in patients with inflammatory bowel disease in real-life settings in Bosnia and Herzegovina;Biomolecules and Biomedicine;2024-09-06

2. Real-world Clinical Effectiveness and Safety of Vedolizumab and Adalimumab in Biologic-naive Patients With Crohn’s Disease;Journal of Clinical Gastroenterology;2024-08-02

3. Upadacitinib Reduces Crohn’s Disease Symptoms Within the First Week of Induction Therapy;Clinical Gastroenterology and Hepatology;2024-08

4. Peripheral blood DNA methylation signatures predict response to vedolizumab and ustekinumab in adult patients with Crohn’s disease: The EPIC-CD study;2024-07-25

5. O USO DO VEDOLIZUMBABE NO TRATAMENTO DA DOENÇA DE CRONH: UMA REVISÃO INTEGRATIVA;REVISTA FOCO;2024-07-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3